These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28762839)

  • 21. Cost-effective treatment of lower respiratory tract infections.
    Garrelts JC; Herrington AM
    Pharmacoeconomics; 1996 Jul; 10(1):36-58. PubMed ID: 10160469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).
    Barrera CM; Mykietiuk A; Metev H; Nitu MF; Karimjee N; Doreski PA; Mitha I; Tanaseanu CM; Molina JM; Antonovsky Y; Van Rensburg DJ; Rowe BH; Flores-Figueroa J; Rewerska B; Clark K; Keedy K; Sheets A; Scott D; Horwith G; Das AF; Jamieson B; Fernandes P; Oldach D;
    Lancet Infect Dis; 2016 Apr; 16(4):421-30. PubMed ID: 26852726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections.
    Calbo E; Garau J
    Respiration; 2005; 72(6):561-71. PubMed ID: 16354997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin.
    Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M
    J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of solithromycin in the management of bacterial community-acquired pneumonia.
    Van Bambeke F; Tulkens PM
    Expert Rev Anti Infect Ther; 2016; 14(3):311-24. PubMed ID: 26848612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geminofloxacin for the management of community-acquired respiratory tract infections.
    Blondeau JM; Tillotson G; Deangelis J
    J Chemother; 2006 Dec; 18(6):582-8. PubMed ID: 17267335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD; Brogden RN
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
    Zhang YY; Huang HH; Ren ZY; Zheng HG; Yu YS; Lü XJ; Xiao ZK; Yang HF; Xiu QY; Chen BY; Yue HM; Hao QL; Huang JA; Ma H; Xiao W; Guo DY; Si B; Sun SH; Zhang W; Li QH; Shen HH; Duan J; Li HY; Yao WZ; Gu JM; Xia QM; Ying KJ; Liu A; Yang HP; Shi MH; Sun TY; Ding GH; Wu GM
    J Infect Chemother; 2009 Oct; 15(5):301-11. PubMed ID: 19856068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance in bacterial pathogens among hospitalized children with community acquired lower respiratory tract infections in Dongguan, China (2011-2016).
    He X; Xie M; Li S; Ye J; Peng Q; Ma Q; Lu X; Zhong B
    BMC Infect Dis; 2017 Sep; 17(1):614. PubMed ID: 28893195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P; Fabbri LM; Bush A
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections].
    Menéndez R; Cantón R; García-Caballero A; Barberán J
    Rev Esp Quimioter; 2019 Dec; 32(6):497-515. PubMed ID: 31795630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lower tract infections as potential indication for therapy with macrolides].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2008 Nov; 25(149):426-8. PubMed ID: 19177781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline.
    Kocsis B; Gulyás D; Szabó D
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the pharmacotherapeutic management of lower respiratory tract infections.
    Cazzola M; Rogliani P; Aliberti S; Blasi F; Matera MG
    Expert Opin Pharmacother; 2017 Jul; 18(10):973-988. PubMed ID: 28480770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrolides and respiratory infection in critically ill patients: what is the next step?
    Lisboa T; Salluh JI; Friedman G
    Minerva Anestesiol; 2016 Feb; 82(2):221-9. PubMed ID: 26375788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections.
    Hawser S; Morrissey I; Lemos B; Keedy K; Fernandes P
    Int J Antimicrob Agents; 2017 Jul; 50(1):17-22. PubMed ID: 28483717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing acute lower respiratory tract infections in an era of antibacterial resistance.
    Volturo GA; Low DE; Aghababian R
    Am J Emerg Med; 2006 May; 24(3):329-42. PubMed ID: 16635707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of new antibiotics in the treatment of acute adult community acquired pneumonia].
    Bondeelle L; Bergeron A; Wolff M
    Rev Mal Respir; 2019 Jan; 36(1):104-117. PubMed ID: 30638789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newer oral antimicrobials for resistant respiratory tract pathogens. Which show the most promise?
    Stein GE; Havlichek DH
    Postgrad Med; 1998 Jun; 103(6):67-70, 74-6. PubMed ID: 9633543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.